Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas

NCT: NCT07715656 · RECRUITING

NCT IDNCT07715656
StatusRECRUITING
Start Date2025-04-09
Completion2027-06-30
SponsorLahey Clinic (OTHER)
First posted
Last updated

Brief Summary

This is a pragmatic, prospective, multicenter, randomized controlled trial with intention to treat analysis. In which subjects will receive either unilateral or bilateral middle meningeal artery (MMA) embolization using coils for the treatment of unilateral chronic subdural hematomas (cSDH).

Frequently Asked Questions

What is Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas?

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas is a clinical trial registered under NCT07715656. Current status: RECRUITING.

What is the status of NCT07715656?

The current status of NCT07715656 (Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas) is: RECRUITING.

When did Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas start?

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas started on 2025-04-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑